Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cholerton

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Pharmacogenetics|June 1, 1994
Debrisoquine 4-hydroxylation (CYP2D6) polymorphism in JordaniansH F Hadidi, S Cholerton, S C Monkman, et al.
Pharmacogenetics|December 1, 1992
The pharmacogenetics of chemical carcinogenesisJ R Idle, M Armstrong, A V Boddy, et al.
British Journal of Clinical Pharmacology|January 1, 1988
The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarinI A Choonara, R G Malia, B P Haynes, et al.
American Journal of Human Genetics|September 1, 1995
A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 allelesP Fernandez-Salguero, S M Hoffman, S Cholerton, et al.
Biochemical Pharmacology|March 29, 1994
Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamideD Walker, J P Flinois, S C Monkman, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Pharmacogenetics|June 1, 1994
Debrisoquine 4-hydroxylation (CYP2D6) polymorphism in JordaniansH F Hadidi, S Cholerton, S C Monkman, et al.
Pharmacogenetics|December 1, 1992
The pharmacogenetics of chemical carcinogenesisJ R Idle, M Armstrong, A V Boddy, et al.
British Journal of Clinical Pharmacology|January 1, 1988
The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarinI A Choonara, R G Malia, B P Haynes, et al.
American Journal of Human Genetics|September 1, 1995
A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 allelesP Fernandez-Salguero, S M Hoffman, S Cholerton, et al.
Biochemical Pharmacology|March 29, 1994
Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamideD Walker, J P Flinois, S C Monkman, et al.
Pageof 4